LVVV — Livewire Ergogenics Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $0.93m
- $4.16m
- $0.58m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.95 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.15 | 0.15 | 0.24 | 0.34 | 0.58 | n/a | n/a | 7.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Livewire Ergogenics, Inc. operates in the cannabis-related health and wellness industry. It is focused on acquiring, leasing, managing, and licensing special-purpose real estate properties conducive to discovering and developing high-end organic-style cannabinoid specialty products in California for medicinal and recreational use. It is managing and licensing a vertically integrated Estate Grown Weedery business model to cultivate and sell handcrafted cannabis products following organic growing guidelines similar to the winery models surrounding Estrella Ranch. Its projects include Estrella Ranch Project, Makana Ola Farms, and SloGrow. The Makana Ola Farms project is a 40-acre parcel with a 9,900 square foot cultivation area located in the heart of Humboldt County in Northern California. It has developed the Estrella Ranch location in Paso Robles, California, into the central hub for all the Company's operations. It also has cannabis cultivation campuses in Coachella, California.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- September 30th, 2015
- Incorporated
- October 9th, 2007
- Public Since
- November 3rd, 2008
- No. of Employees
- 1
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,859,979,092
- Address
- 1600 N Kraemer Blvd., ANAHEIM, 92806
- Web
- https://livewireergogenics.com/
- Phone
- +1 7147777851
- Contact
- John Davenport
- Auditors
- RBSM LLP
Upcoming Events for LVVV
Q2 2025 Livewire Ergogenics Inc Earnings Release
Similar to LVVV
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
What is the Livewire Ergogenics share price?
As of Today at 21:47 UTC, shares in Livewire Ergogenics are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Livewire Ergogenics share price performed this year?
Shares in Livewire Ergogenics last closed at $0.00 and the price had moved by -72.22% over the past 365 days. In terms of relative price strength the Livewire Ergogenics share price has underperformed the S&P500 Index by -73.75% over the past year.
What are the analyst and broker recommendations for Livewire Ergogenics?
There is no consensus recommendation for this security.
Find out moreWhat is the Livewire Ergogenics dividend yield?
Livewire Ergogenics does not currently pay a dividend.
Does Livewire Ergogenics pay a dividend?
Livewire Ergogenics does not currently pay a dividend.
When does Livewire Ergogenics next pay dividends?
Livewire Ergogenics does not currently pay a dividend.
How do I buy Livewire Ergogenics shares?
To buy shares in Livewire Ergogenics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Livewire Ergogenics?
As of the previous close price of $0.00, shares in Livewire Ergogenics had a market capitalisation of $0.93m.
Where are Livewire Ergogenics shares listed?
Here are the trading details for Livewire Ergogenics:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: LVVV
What kind of share is Livewire Ergogenics?
Based on an overall assessment of its quality, value and momentum Livewire Ergogenics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Livewire Ergogenics share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Livewire Ergogenics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Livewire Ergogenics. Over the past six months, its share price has underperformed the S&P500 Index by -43.15%.
As of the last closing price of $0.00, shares in Livewire Ergogenics were trading -46.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Livewire Ergogenics PE Ratio?
The Livewire Ergogenics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Livewire Ergogenics?
Livewire Ergogenics' management team is headed by:
- Cliff Rusin - PRE
- William Hodson - CEO